Josep Maria Llovet

Institution information unavailable

Research Areas

Discover Papers by Josep Maria Llovet

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

156

Publications

802

Citations

157345

i10-index

355

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Sorafenib in Advanced Hepatocellular Carcinoma	2008	12944
EASL Clinical Practice Guidelines: Management of h...	2018	11424
Hepatocellular carcinoma	2021	6490
Modified RECIST (mRECIST) Assessment for Hepatocel...	2010	4338
Clinical Management of Hepatocellular Carcinoma. C...	2001	4099
Hepatocellular carcinoma	2012	4026
Prognosis of Hepatocellular Carcinoma: The BCLC St...	1999	3816
Regorafenib for patients with hepatocellular carci...	2016	3662
Hepatocellular carcinoma	2003	3613
Arterial embolisation or chemoembolisation versus ...	2002	3502

Publications

1.
Sorafenib in Advanced Hepatocellular Carcinoma
Year: 2008Citations: 12944DOI: 10.1056/nejmoa0708857
2.
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Year: 2018Citations: 11424DOI: 10.1016/j.jhep.2018.03.019
3.
Hepatocellular carcinoma
Year: 2021Citations: 6490DOI: 10.1038/s41572-020-00240-3
4.
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Year: 2010Citations: 4338DOI: 10.1055/s-0030-1247132
5.
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Year: 2001Citations: 4099DOI: 10.1016/s0168-8278(01)00130-1
6.
Hepatocellular carcinoma
Year: 2012Citations: 4026DOI: 10.1016/s0140-6736(11)61347-0
7.
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Year: 1999Citations: 3816DOI: 10.1055/s-2007-1007122
8.
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Year: 2016Citations: 3662DOI: 10.1016/s0140-6736(16)32453-9
9.
Hepatocellular carcinoma
Year: 2003Citations: 3613DOI: 10.1016/s0140-6736(03)14964-1
10.
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial
Year: 2002Citations: 3502DOI: 10.1016/s0140-6736(02)08649-x

About Josep Maria Llovet

Josep Maria Llovet is a researcher with 802 publications and 157345 citations. Their research focuses on . With an h-index of 156, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Josep Maria Llovet and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year